Alto Predict consults on the use of human cell-based alternatives to animals (In Vitro NAMs) to advance human-relevant science and make better decisions in drug discovery and product development. We provide guidance on commercialization and regulatory strategies, as well as support R&D teams in the design of modern data foundations that support AI-ready assay data. 

	•	Assay & Platform Development: Validation and Commercialization Strategies
	•	Data Standards & Regulatory Alignment: Data Strategy and Governance
	•	Drug Discovery: Integration of NAMs for Program De-risking

Alto Predict is also creating a database and registry (CHITA) of commercially available human in vitro NAMs. Our long term objective is to collect and structure reference data from these assays for ingestion by AI-based reasoning systems to support better decision-making in drug discovery, toxicology, and product development. 

Alto Predict

Org chart

Teams

Offices